(19)
(11) EP 3 649 985 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.04.2021 Bulletin 2021/16

(45) Mention of the grant of the patent:
17.03.2021 Bulletin 2021/11

(21) Application number: 19219651.7

(22) Date of filing: 08.12.2010
(51) International Patent Classification (IPC): 
A61F 2/24(2006.01)
A61M 25/01(2006.01)
A61L 27/06(2006.01)
A61F 2/82(2013.01)
 A61M 29/00(2006.01)
A61L 27/04(2006.01)
A61L 27/14(2006.01)

(54)

DEVICE AND SYSTEM FOR TRANSCATHETER MITRAL VALVE REPLACEMENT

VORRICHTUNG UND SYSTEM ZUR NEUPLATZIERUNG EINER TRANSKATHETER-MITRALKLAPPE

DISPOSITIF ET SYSTÈME DE REMPLACEMENT DE VALVULE MITRALE PAR TRANSCATHÉTER

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 08.12.2009 US 26773909 P

(43) Date of publication of application:
13.05.2020 Bulletin 2020/20

(60) Divisional application:
21155338.3

(62) Application number of the earlier application in accordance with Art. 76 EPC:
17182203.4 / 3300695
10836657.6 / 2509538

(73) Proprietors:
  • Avalon Medical Ltd.
    Stillwater, MN 55082 (US)
  • Colorado State University Research Foundation
    Fort Collins, CO 80526 (US)

(72) Inventors:
  • SCHANKERELI, Kemal
    Stillwater, MN 55082 (US)
  • ORTON, E. Christopher
    Fort Collins, MN 80525 (US)

(74) Representative: Gill Jennings & Every LLP 
MTH The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)


(56) References cited: : 
WO-A1-2009/132187
US-A1- 2006 058 872
 DE-A1-102007 043 830
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).